Literature DB >> 22307896

Environmental metabolites of fluoroquinolones: synthesis, fractionation and toxicological assessment of some biologically active metabolites of ciprofloxacin.

Gareth Lewis1, Albert Juhasz, Euan Smith.   

Abstract

BACKGROUND, AIM, AND SCOPE: Biowastes produced by humans and animals are routinely disposed of on land, and concern is now growing that such practices provide a pathway for fluoroquinolone (FQs) antibacterial agents and their environmental metabolites (FQEMs) to contaminate the terrestrial environment. The focus of concern is that FQs and FQEMs may accumulate in amended soils to then adversely impact on the terrestrial environment. One postulated impact is the development of a selective environment in which FQ-resistant bacteria may grow. To find evidence in support of an accumulation of antibacterial-like activity, it was first necessary to establish whether any biologically active FQEMs could be synthesized by physicochemical factors that are normally present in the environment. However, many FQEMs are not commercially available to be used as standards in such studies. FQEMs were therefore synthesized using well-defined processes. They were subsequently analyzed using spectroscopy (UV-vis) and high performance liquid chromatography with mass spectral detection. The antibacterial-like activities of fractionated FQEMs were then assessed in novel bacterial growth inhibition bioassays, and results were compared to those obtained from instrumental analyses.
MATERIALS AND METHODS: Parent FQs were either exposed to sunlight or were synthesized using defined aerobic microbial (Mycobacterium gilvum or a mixed culture derived from an agricultural soil) fermentation processes. Mixtures of FQEMs derived from photo- and (intracellular) microbial processes were isolated by preparative chromatography and centrifugation techniques, respectively. Mixtures were subsequently fractionated using analytical high-performance thin layer chromatography (HPTLC), and excised analytes were tested in bioautography assays for their antibacterial-like activities. Two bacteria, Escherichia coli (E. coli) and Azospirillum brasilense (A. brasilense) were used as reporter organisms in testing FQ standards and any subtle differences between biologically active FQEMs of ciprofloxacin (CF). RESULTS AND DISCUSSION: FQEMs produced in the photo-synthetic process had UV-vis profiles that were indistinguishable from the parent FQs, and yet mass spectral data revealed the presence of N-formylciprofloxacin (FCF). In contrast, the UV-vis profiles of FQEMs synthesized by M. gilvum and a mixed culture of microorganisms had UV-vis profiles that were similar to one another and markedly different to the parent fluoroquinolones. Mass spectral studies confirmed the presence of FCF and N-acetylciprofloxacin in both microbial ferments. In addition, a photo-FQEM (Cp 6), three M. gilvum FQEMs (Cm 5, Cm 8, and Cm 10) and a mixed culture FQEM (Cs 6) of CF and many other FQEMs of CF, norfloxacin (NF), and enrofloxacin (EF) were fractionated using HPTLC, although their identities have yet to be confirmed. Differences between bioautography results were obtained when E. coli or A. brasilense were used as reporter organisms. Parent FQs (CF and EF) and the FQEMs of CF (Cp 6, Cm 8, and Cs 6) displayed antibacterial-like activity when using E. coli as the reporter organism. In contrast, A. brasilense was insensitive to parent CF and sensitive to EF and all tested FQEMs of CF. Results are consistent with photo- and microbial processes modifying CF in different ways, with the latter changing the UV-vis chromophores. It can be inferred that a lack of detection of analytes (especially photo-FQEMs) when using UV-vis does not necessarily indicate an absence of analyte. Additionally, similarities between the UV-vis profiles of FQEMs extracted from the (monoculture) M. gilvum and the mixed culture microbial aerobic ferments are consistent with similar processes operating in both ferments. Results of HPTLC and bioautography studies revealed that mixtures of (photo- and microbial) FQEMs could be fractionated into individual components.
CONCLUSIONS: Bioactive FQEMs of ciprofloxacin, as a representative FQ, can be synthesized by photo- and microbial processes, and their detection required the use of both instrumental and bioautography analytical techniques. It is likely that such FQEMs will also be present on agricultural land that has been repeatedly amended with FQ-contaminated biosolids. RECOMMENDATIONS AND PERSPECTIVES: The use of instrumental analytical techniques alone and especially photometric detection techniques will underestimate antibacterial-like activities of FQEMs. Moreover, the extraction technique(s) and the selected toxicological endpoint(s) require careful consideration when assessing bioactivity. It is therefore recommended that instrumental analytical techniques and several bioautography assays be performed concurrently, and bioautography assays should use a variety of reporter organisms. Two types of bacterial growth bioassays are recommended in any assessment of antibacterial-like activity derived from CF (and possibly from other FQs). A standardized E. coli bioassay should be used as a general screening procedure to facilitate intra- and inter-laboratory exchange of data. Additionally, soil-specific (region-specific) growth inhibition bioassays should be undertaken using several species of endemic soil bacteria. It is likely that the two sets of data will be useful in future risk assessment processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307896     DOI: 10.1007/s11356-012-0766-7

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  37 in total

1.  Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil.

Authors:  Eva M Golet; Irene Xifra; Hansruedi Siegrist; Alfredo C Alder; Walter Giger
Journal:  Environ Sci Technol       Date:  2003-08-01       Impact factor: 9.028

2.  Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms.

Authors:  Evelyn Walters; Kristin McClellan; Rolf U Halden
Journal:  Water Res       Date:  2010-07-27       Impact factor: 11.236

3.  A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog.

Authors:  C C Cester; P L Toutain
Journal:  J Pharm Sci       Date:  1997-10       Impact factor: 3.534

Review 4.  Mode of action of microbial bioactive metabolites.

Authors:  V Bethal
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

5.  Microbial diversity of soil bacteria in agricultural field contaminated with heavy metals.

Authors:  Chihching Chien; Yumei Kuo; Changchieh Chen; Chunwei Hung; Chihwei Yeh; Weijen Yeh
Journal:  J Environ Sci (China)       Date:  2008       Impact factor: 5.565

6.  Treatment of uncomplicated urinary tract infections with temafloxacin.

Authors:  A Iravani
Journal:  Am J Med       Date:  1991-12-30       Impact factor: 4.965

7.  Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.

Authors:  A Anadón; M R Martínez-Larrañaga; M J Díaz; M L Fernández-Cruz; M A Martínez; M T Frejo; M Martínez; J Iturbe; M Tafur
Journal:  Am J Vet Res       Date:  1999-11       Impact factor: 1.156

8.  In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.

Authors:  J D Gay; D R DeYoung; G D Roberts
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

9.  Quinolones in the treatment of uncomplicated urinary tract infections.

Authors:  R R Bailey
Journal:  Int J Antimicrob Agents       Date:  1992-12       Impact factor: 5.283

10.  Primary photoproducts and half-lives.

Authors:  J Burhenne; M Ludwig; P Nikoloudis; M Spiteller
Journal:  Environ Sci Pollut Res Int       Date:  1997       Impact factor: 4.223

View more
  2 in total

Review 1.  Microbial transformations of antimicrobial quinolones and related drugs.

Authors:  Igor A Parshikov; John B Sutherland
Journal:  J Ind Microbiol Biotechnol       Date:  2012-09-25       Impact factor: 3.346

Review 2.  How Safe are Fluoroquinolones for Diabetic Patients? A Systematic Review of Dysglycemic and Neuropathic Effects of Fluoroquinolones.

Authors:  Abdulrhman Althaqafi; Long Chiau Ming; Majid Ali; Yusuf Alzahrani; Zahid Hussain
Journal:  Ther Clin Risk Manag       Date:  2021-10-13       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.